Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6455 USD | -0.71% | -0.75% | -13.43% |
05-07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.43% | 13.71M | |
+28.33% | 49.18B | |
+0.76% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.82% | 26.09B | |
-22.44% | 18.71B | |
+7.79% | 13.26B | |
+32.49% | 12.32B | |
-0.43% | 11.99B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q1 2023 Earnings Call, May 15, 2023